Our portfolio

Portfolio
Overview: PDF Excel Click here to open search box

Search in site

IP Group holding: 38.0%*

Terabit-scale encryption-proof customer insights platform

Deeptech

IP Group holding: 23.2%*

Breakthrough chemistry changing the economics of carbon capture

Cleantech

IP Group holding: 2.1%*

Clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients

Life Sciences
Top 20 holdings

IP Group holding: 14.3%*

Immuno-oncology company developing novel, targeted T cell enhancing therapeutics

Life Sciences
Top 20 holdings

IP Group holding: 14.6%*

Developing the next generation of image and video compression technology using an AI-first approach

Deeptech

IP Group holding: 29.5%*

AI automation of computer code testing

Deeptech

IP Group holding: 19.6%*

Novel disease modifying medications for respiratory disease

Life Sciences

IP Group holding: 20.1%*

Leading predictive analytics company

Deeptech
Top 20 holdings

IP Group holding: 27.5%*

Solving fusion with the simplest possible machine.

Cleantech
Top 20 holdings

IP Group holding: 23.6%*

Anti-malware solutions for enterprise cyber defences

Deeptech
Top 20 holdings

IP Group holding: 9.7%*

Using large-scale genetic information to develop precision healthcare tools and to bring new understanding to drug discover

Life Sciences

IP Group holding: 36.8%*

Mobile assessment and training platform for home-based upper limb rehabilitation

Life Sciences

*Holding percentages in portfolio companies reflect the undiluted beneficial equity interest excluding debt, unless otherwise explicitly stated.

Showing XX of 66

IP Group holding: 9.5%*

Develops medicines for the treatment of primary mitochondrial diseases

Life Sciences

IP Group holding: 26.4%*

Developing a high performance decoding solution for 5G mobile communication

Deeptech
Top 20 holdings

IP Group holding: 39.2%*

3D printing quality monitoring

Deeptech

IP Group holding: 19.0%*

Clinical stage oncology company based on a tumor-specific immuno-gene therapy platform

Life Sciences

IP Group holding: 34.8%*

Medical devices to improve the safety, efficiency and outcomes of advanced surgical procedures

Life Sciences

IP Group holding: 21.5%*

Next-generation technology for gastric disorders

Life Sciences

IP Group holding: 34.0%*

Long-range and efficient eVTOL

Cleantech

IP Group holding: 25.2%*

Unique solutions for encapsulation based on cutting-edge research

Deeptech

IP Group holding: 7.3%*

Novel oncology therapies that leverage the changes in the DNA Damage Response (DDR) in cancer cells

Life Sciences
Top 20 holdings

IP Group holding: 34.0%*

Personalised, trackable 3D sound projection technology

Deeptech

IP Group holding: 32.0%*

Novel heat exchanger technology

Cleantech

IP Group holding: 31.6%*

The fuel cell company with Gigafactories

Cleantech
Top 20 holdings

IP Group holding: 38.0%*

Terabit-scale encryption-proof customer insights platform

Deeptech

IP Group holding: 23.2%*

Breakthrough chemistry changing the economics of carbon capture

Cleantech

IP Group holding: 2.1%*

Clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients

Life Sciences
Top 20 holdings

IP Group holding: 14.3%*

Immuno-oncology company developing novel, targeted T cell enhancing therapeutics

Life Sciences
Top 20 holdings

IP Group holding: 14.6%*

Developing the next generation of image and video compression technology using an AI-first approach

Deeptech

IP Group holding: 29.5%*

AI automation of computer code testing

Deeptech

IP Group holding: 19.6%*

Novel disease modifying medications for respiratory disease

Life Sciences

IP Group holding: 20.1%*

Leading predictive analytics company

Deeptech
Top 20 holdings

IP Group holding: 27.5%*

Solving fusion with the simplest possible machine.

Cleantech
Top 20 holdings

IP Group holding: 23.6%*

Anti-malware solutions for enterprise cyber defences

Deeptech
Top 20 holdings

IP Group holding: 9.7%*

Using large-scale genetic information to develop precision healthcare tools and to bring new understanding to drug discover

Life Sciences

IP Group holding: 36.8%*

Mobile assessment and training platform for home-based upper limb rehabilitation

Life Sciences

IP Group holding: 14.2%*

Perovskite-based light-emitting devices for next-gen displays

Deeptech

IP Group holding: 1.8%*

Digital clinic for joint and muscle care

Life Sciences
Top 20 holdings

IP Group holding: 37.0%*

Developing a new type of breakthrough hydrogen electrolyser and accelerating the global transition to net zero

Cleantech
Top 20 holdings

IP Group holding: 35.9%*

Software for the early identification of osteoporosis from an X-ray image

Life Sciences

IP Group holding: 31.5%*

Creating scalable, effective, and highly personalised digital mental health products

Life Sciences
Top 20 holdings

IP Group holding: 21.5%*

Next-generation antibody-drug conjugates (ADCs) for cancer therapy

Life Sciences

IP Group holding: 26.0%*

Early-stage drug discovery using insulin-regulated aminopeptidase (IRAP) as a novel target in fibrosis

Life Sciences

IP Group holding: 20.8%*

Virtual reality simulation for ultrasound training and AI-based software tools to improve clinical diagnostic ultrasound

Life Sciences

IP Group holding: 24.9%*

Silicon-based resistive random access memory (RRAM) technology

Deeptech

IP Group holding: 56.5%*

From disease modification to disease resolution

Life Sciences
Top 20 holdings

IP Group holding: 8.3%*

Novel polymers, e.g. "removable chewing gum"

Deeptech

IP Group holding: 2.2%*

A holding company making impact investments in game-changing plant-based businesses

Cleantech

IP Group holding: 18.2%*

Developing breakthrough therapies at the interface between inflammation, immunity and metabolism

Life Sciences

IP Group holding: 31.2%*

Software for optical neural networks

Deeptech

IP Group holding: 50.0%*

Contactless, lubricant-free magnetic gear systems

Cleantech

IP Group holding: 17.7%*

Microbiome based therapeutics and diagnostics

Life Sciences
Top 20 holdings

IP Group holding: 21.3%*

Drug development company targeting the ubiquitin pathway for the treatment of serious diseases

Life Sciences
Top 20 holdings

IP Group holding: 22.6%*

Internet of Tanks reducing energy consumption and enabling renewables

Cleantech

IP Group holding: 8.6%*

Focused on the discovery of a new generation of sustainable herbicides.

Life Sciences

IP Group holding: 12.1%*

No-code AI for product engineering

Deeptech

IP Group holding: 6.8%*

Mapping technologies for indoor areas

Deeptech

IP Group holding: 5.2%*

Silicon anodes for next generation lithium-ion batteries

Cleantech
Top 20 holdings

IP Group holding: 11.8%*

Software to enable every vehicle to become autonomous

Cleantech
Top 20 holdings

IP Group holding: 18.4%*

Catalyst to convert CO2 and Hydrogen into synthetic fuels

Cleantech

IP Group holding: 27.7%*

Global leader in vision-based patient monitoring systems

Life Sciences

IP Group holding: 9.6%*

Enabling the analysis of any living thing, by any person, in any environment using real-time DNA/RNA sequencing

Life Sciences
Top 20 holdings

IP Group holding: 1.5%*

Achieving quantum computing through super conducting circuits

Deeptech

IP Group holding: 1.8%*

Contractually preferred partner of the University of Oxford to develop spin-out companies based on divisional research

Top 20 holdings

IP Group holding: 11.8%*

Novel inhaled treatment for life-threatening fungal lung infections

Life Sciences
Top 20 holdings

IP Group holding: 17.6%*

The world’s first compact completely embedded self-certified quantum random number generator

Deeptech

IP Group holding: 7.3%*

Creating a scalable, high-density quantum computer on a silicon chip for the cloud

Deeptech

IP Group holding: 19.0%*

Novel therapies for chronic respiratory inflammation

Life Sciences

IP Group holding: 31.9%*

Developing the world’s lowest cost flow battery

Cleantech

IP Group holding: 13.8%*

Wireless, programmable construction kits for creative kids

Deeptech

IP Group holding: 6.1%*

Visual tracking and mapping systems or 'Simultaneous Localisation and Mapping' (SLAM)

Deeptech

IP Group holding: 12.1%*

Clinical stage biotechnology company creating novel therapies that inhibit RNA modifying enzymes for use in oncology

Life Sciences

IP Group holding: 1.8%*

Smart home climate management and smart energy tariffs

Cleantech

IP Group holding: -%*

Fast and secure payment solutions that can help businesses to better manage and grow their operations

Deeptech

IP Group holding: 9.1%*

International medical technology company, focusing on the development of regenerative products

Life Sciences

IP Group holding: 20.4%*

Removing boundaries between physical and digital worlds - for anyone, anywhere

Deeptech
Top 20 holdings

IP Group holding: 11.0%*

Reusable packing-as-a-service for food take-away and delivery

Cleantech

Backing tech-enabled solutions that empower women & serve their overlooked needs in FemTech, FinTech, EdTech & Family Tech

Backing the daring, rewarding the brave.